Weintraub Bennett
SEC insider (Form 3/4/5 filer). CIK 0002040378. Director at Apimeds Pharmaceuticals US, Inc. (APUS). 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 11, 2025. Located in HOPEWELL, NJ.
Companies Weintraub Bennett has filed insider reports for
- Apimeds Pharmaceuticals US, Inc. (APUS): Director
Weintraub Bennett
CIK: 0002040378
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apimeds Pharmaceuticals US, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Nov 11, 2025APUS
Apimeds Pharmaceuticals US, Inc.
AwardDirectStock Option (right to buy)
10K shares- - Oct 15, 2025APUS
Apimeds Pharmaceuticals US, Inc.
AwardDirectStock Option (right to buy)
3K shares- - May 16, 2025APUS
Apimeds Pharmaceuticals US, Inc.
AwardDirectStock Option (right to buy)
5.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 11, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| Oct 15, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | Award Stock Option (right to buy) | 3,000 | - | - | Direct |
| May 16, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | Award Stock Option (right to buy) | 5,780 | - | - | Direct |
1-3 of 3 transactions